Cargando…

Exosomes as A Next-Generation Diagnostic and Therapeutic Tool in Prostate Cancer

Extracellular vesicles (EVs) have brought great momentum to the non-invasive liquid biopsy procedure for the detection, characterization, and monitoring of cancer. Despite the common use of PSA (prostate-specific antigen) as a biomarker for prostate cancer, there is an unmet need for a more specific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gaglani, Simita, Gonzalez-Kozlova, Edgar, Lundon, Dara J., Tewari, Ashutosh K., Dogra, Navneet, Kyprianou, Natasha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465219/ https://www.ncbi.nlm.nih.gov/pubmed/34576294 http://dx.doi.org/10.3390/ijms221810131

Ejemplares similares

Inflammation as a Driver of Prostate Cancer Metastasis and Therapeutic Resistance
por: Archer, Maddison, et al.
Publicado: (2020)

Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
por: Chakravarty, Dimple, et al.
Publicado: (2020)

Clinical Significance of Extracellular Vesicles in Prostate and Renal Cancer
por: Chen, Tzu-Yi, et al.
Publicado: (2023)

COVID-19 vaccination: Prioritization of at risk groups
por: Lundon, Dara J., et al.
Publicado: (2021)

Extracellular vesicles carry distinct proteo-transcriptomic signatures that are different from their cancer cell of origin
por: Chen, Tzu-Yi, et al.
Publicado: (2022)

Multiphoton Microscopy for Identifying Collagen Signatures Associated with Biochemical Recurrence in Prostate Cancer Patients
por: Pavlova, Ina P., et al.
Publicado: (2021)

Increased Hospitalization and Mortality from COVID-19 in Prostate Cancer Patients
por: Chakravarty, Dimple, et al.
Publicado: (2021)

A COVID-19 Test Triage Tool, Predicting Negative Results and Reducing the Testing Burden on Healthcare Systems During a Pandemic
por: Lundon, Dara J., et al.
Publicado: (2021)

Exosomes in the Repair of Bone Defects: Next-Generation Therapeutic Tools for the Treatment of Nonunion
por: Lu, Jian, et al.
Publicado: (2019)

Circadian Rhythm Disruption as a Contributor to Racial Disparities in Prostate Cancer
por: Dasari, Sonali S., et al.
Publicado: (2022)

COVID-19 and Kidney Disease: Molecular Determinants and Clinical Implications in Renal Cancer
por: Mihalopoulos, Meredith, et al.
Publicado: (2020)

Profiling Prostate Cancer Therapeutic Resistance
por: Wade, Cameron A., et al.
Publicado: (2018)

Exosomes in Diabetic Cardiomyopathy: The Next-Generation Therapeutic Targets?
por: Sahoo, Susmita, et al.
Publicado: (2016)

Social Determinants Predict Outcomes in Data From a Multi-Ethnic Cohort of 20,899 Patients Investigated for COVID-19
por: Lundon, Dara J., et al.
Publicado: (2020)

Inflammation in prostate cancer progression and therapeutic targeting
por: Stark, Timothy, et al.
Publicado: (2015)

Early mortality risk stratification after SARS-CoV-2 infection
por: Lundon, D.J., et al.
Publicado: (2021)

Early mortality risk stratification after SARS-CoV-2 infection
por: Lundon, D.J., et al.
Publicado: (2021)

The human neurosecretome: extracellular vesicles and particles (EVPs) of the brain for intercellular communication, therapy, and liquid-biopsy applications
por: Soleymani, Taliah, et al.
Publicado: (2023)

Androgen Receptor as a Driver of Therapeutic Resistance in Advanced Prostate Cancer
por: Kahn, Barbara, et al.
Publicado: (2014)

Tools for the next generation
Publicado: (2022)

The Evolving Clinical Management of Genitourinary Cancers Amid the COVID-19 Pandemic
por: Izadmehr, Sudeh, et al.
Publicado: (2021)

Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics
por: Yang, Emily Y., et al.
Publicado: (2020)

Metagenomic next-generation sequencing as a diagnostic tool for toxoplasmic encephalitis
por: Hu, Zhiliang, et al.
Publicado: (2018)

Exosomes as Novel Diagnostic Biomarkers and Therapeutic Tools in Gliomas
por: Skouras, Panagiotis, et al.
Publicado: (2023)

Bioengineering of Extracellular Vesicles: Exosome-Based Next-Generation Therapeutic Strategy in Cancer
por: Saha, Priyanka, et al.
Publicado: (2021)

Mechanisms navigating the TGF-β pathway in prostate cancer
por: Cao, Zheng, et al.
Publicado: (2015)

Association between Expression of Connective Tissue Genes and Prostate Cancer Growth and Progression
por: Treacy, Patrick-Julien, et al.
Publicado: (2023)

Deciphering Evolutionary Dynamics and Lineage Plasticity in Aggressive Prostate Cancer
por: Kyprianou, Natasha, et al.
Publicado: (2021)

Anoikis in phenotypic reprogramming of the prostate tumor microenvironment
por: Nepali, Prerna R., et al.
Publicado: (2023)

Next generation diagnostics on cardiomyopathy
por: Blouin, Jean-Louis, et al.
Publicado: (2014)

The Roles of Exosomes as Future Therapeutic Agents and Diagnostic Tools for Glioma
por: Wu, Xiaoben, et al.
Publicado: (2021)

A Decision Aide for the Risk Stratification of GU Cancer Patients at Risk of SARS-CoV-2 Infection, COVID-19 Related Hospitalization, Intubation, and Mortality
por: Lundon, Dara J., et al.
Publicado: (2020)

Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression
por: Grant, Campbell M., et al.
Publicado: (2013)

Milk Exosomes: Next-Generation Agents for Delivery of Anticancer Drugs and Therapeutic Nucleic Acids
por: Timofeeva, Anna M., et al.
Publicado: (2023)

Exosomes: Potential Next-Generation Nanocarriers for the Therapy of Inflammatory Diseases
por: Mori, Tosca, et al.
Publicado: (2023)

Evaluation of exosomal miRNAs as potential diagnostic biomarkers for acute myocardial infarction using next-generation sequencing
por: Guo, Mei, et al.
Publicado: (2021)

Translational Bioinformatics for Diagnostic and Prognostic Prediction of Prostate Cancer in the Next-Generation Sequencing Era
por: Chen, Jiajia, et al.
Publicado: (2013)

Regulatory T Cell-Derived Exosomes: Possible Therapeutic and Diagnostic Tools in Transplantation
por: Agarwal, Akansha, et al.
Publicado: (2014)

Guidelines for diagnostic next-generation sequencing
por: Matthijs, Gert, et al.
Publicado: (2016)

Epigenetic mechanisms underlying subtype heterogeneity and tumor recurrence in prostate cancer
por: Chakraborty, Goutam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dnc39vfoold2uiujnhggn5vi92